Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.

By M. Reger, G. Watson, William H Frey II, L. Baker, B. Cholerton, M. Keeling, D. Belongia, S. Plymate, G. Schellenberg, M. Cherrier and 1 more. Neurobiology of Aging, 2006

644 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Cognitive Neuroscience, Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/645698386be4799d2fa4786b56e266402bee1006

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Biochemistry

1. C. Zhong
2. Zhichun Chen

Citations in the corpus

• Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. (2013, background): “…shown to improve memory and attention abilities without significant adverse effects as well as changes in blood levels of insulin or glucose (Benedict et al., 2008; Craft et al., 2012; Dhamoon et al., 2009; Djupesland, 2008; Reger et al., 2006, 2008a,b; Schioth et al., 2012; Shemesh et al., 2012).”
• Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. (2010, background): “Here we describe specific and significant alterations in IGF-1R, IR, and their key substrate adaptor proteins IRS-1 and IRS- in Alzheimer’s disease (AD).”